A Phase 2/3, Observer-Blind, Randomised, Controlled Study to Assess the Safety and Immunogenicity of SII-ChAdOx1 nCOV-19 (COVID-19 Vaccine) in Adults in India

Prasad S. Kulkarni; Chandrasekaran Padmapriyadarshini; Johan Vekemans; Ashish Bavdekar; Madhu Gupta; Praveen Kulkarni; B. S. Garg; Nithya J. Gogtay; Muralidhar Tambe; Sanjay Lalwani; Kiranjit Singh; Renuka Munshi; Sushant Meshram; T. S. Selvavinayagam; Krishna Pandey; Devi Madhavi Bhimarasetty; S. R. Ramakrishnan; Chetanraj Bhamare; Abhijeet Dharmadhikari; Rajeev Vadakkedath; Cyrille J. Bonhomme; Madhuri Thakar; Swarali N. Kurle; Elizabeth J. Kelly; Manish Gautam; Nivedita Gupta; Samiran Panda; Balram Bhargava; Umesh Shaligram; Dhananjay Kapse; Bhagwat Gunale; COVISHIELD Study Group

SSRN Electronic Journal (2021) - Comments
doi: 10.2139/ssrn.3901791 issn: 1556-5068

Prasad S. Kulkarni, Chandrasekaran Padmapriyadarshini, Johan Vekemans, Ashish Bavdekar, Madhu Gupta, Praveen Kulkarni, B. S. Garg, Nithya J. Gogtay, Muralidhar Tambe, Sanjay Lalwani, Kiranjit Singh, Renuka Munshi, Sushant Meshram, T. S. Selvavinayagam, Krishna Pandey, Devi Madhavi Bhimarasetty, S. R. Ramakrishnan, Chetanraj Bhamare, Abhijeet Dharmadhikari, Rajeev Vadakkedath